“…For the muscle relaxants pancuronium bromide, Org 6368 (2, 16-dipiperidino-5-androstan-3-ol acetate dimethobromide), Org NC 45 (N-methyl-N-(3,17-diacetoxy-2-piperidino-5-androstan-16yl)piperidinium bromide) a new monoquaternary analogue of pancuronium bromide, and tubocurarine, the liver plays a central role in the pharmacokinetics in various species (Agoston, Kersten and Meijer, 1973;Agoston et aj., 1973;Agoston et al, 1977;Ham et al, 1978;Durant, Houwertjes and Agoston, 1979;Meijer et al, 1979). Somogyi, Shanks and Triggs (1977) reported a prolongation of neuromuscular blockade by pancuronium bromide in patients with extrahepatic cholestasis as a result of a decrease in systemic clearance.…”